Injecting drug use continues to be the most important risk factor for HCV infection in the UK. Data from the Unlinked Anonymous Monitoring (UAM) survey of people who inject drugs (PWID) suggest that levels of infection in this group remain high in 2013 (50% in England, 32% in Northern Ireland and 47% in Wales); in 2013 to 2014, 57% of PWID surveyed in Scotland tested positive for antibodies to hepatitis C.
The National Institute for Health and Care Excellence (NICE) has published two public health guidance documents on NSPs: PH18 (2009)1 and PH52 (2014). 2 The economic arguments for NSP investment come from the economic modelling report accompanying PH18. Modellers explored the level of syringe coverage, opiate substitution therapy (OST) participation, and hepatitis C treatment required to reduce HIV and hepatitis C prevalence among people who inject drugs.
This guidance makes recommendations on needle and syringe programmes, including those provided by pharmacies and drugs services for adults and young people (including those under 16) who inject drugs, including image- and performance-enhancing drugs.
This report describes time trends on the extent of infections among people who inject drugs in the UK to the end of 2012. This year’s report focuses on the changing nature of injecting drug use.
Guide to Developing and Managing Syringe Access Programs from the Harm Reduction Coalition in the US is a comprehensive, step-by-step manual for starting and managing syringe access programs.
In this new consolidated guidelines document on HIV prevention, diagnosis, treatment and care for key populations, the World Health Organization brings together all existing guidance relevant to five key populations – men who have sex with men, people who inject drugs, people in prisons and other closed settings, sex workers and transgender people – and updates selected guidance and recommendations.
Scottish Drugs Forum in conjunction with NHS Greater Glasgow & Clyde and Frontier Medical have created a new advice booklet for people injecting New Psychoative Substances (NPS). The guide is intended to inform people of the risks associated with injecting NPS, drugs commonly called legal highs, or any unidentified white powders.
This toolkit from the Harm Reduction Coalition in the US is intended to provide examples of policies and practices from current PDSE programs so new and existing programs can think about and incorporate the parts that work for them. It gives an overview of points to consider in starting a PDSE program and is intended to generate new ideas for revising and improving existing PDSE programs.
This guide is designed to assist in expanding the response to HIV among injecting drug users globally. The transmission of HIV among injecting drug users and related populations of sex workers, youth and other vulnerable people is greatly adding to the burden of disease in countries worldwide. Evidence from 20 years of research shows that needle and syringe programmes (NSPs) prevent, control and ultimately reduce prevalence of HIV and other blood-borne infections among injecting drug users.